| Financial Year |
March 31 2023 |
| Monetary Funds |
6,075,588,786.88 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
799,231,131.43 |
| Advances to Suppliers |
135,130,913.22 |
| Other Receivables |
231,350,321.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
26,087,700.00 |
| Inventories |
226,883,424.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
43,303,932.96 |
| Total Current Assets |
8,259,157,998.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
312,351,906.22 |
| Investment Properties |
-- |
| Fixed Assetes |
8,109,627,429.19 |
| Under-construction Projects |
1,009,002,983.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,448,171,751.31 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
30,736,017.98 |
| Deferred Income Tax Assets |
767,861,340.62 |
| Other Non-Current Assets |
50,623,171.63 |
| Sub-Total of Non-Current Assets |
14,775,656,895.00 |
| Total Assets |
23,034,814,893.14 |
| Short-Term Loans |
5,172,810,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
964,170,822.12 |
| Accounts Payable |
2,399,776,425.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
953,628,684.58 |
| Taxes Payable |
154,331,493.83 |
| Interest Payable |
-- |
| Dividend Payable |
12,423,390.32 |
| Other payables |
1,237,868,698.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
78,228,284.67 |
| Other Current Liabilities |
69,317,724.62 |
| Sub-Total of Current Liabilities |
11,579,764,446.38 |
| Long-term Loans |
812,599,475.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
130,703,484.29 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,212,220,877.05 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,411,391,020.73 |
| Total Liabilities |
13,991,155,467.11 |
| Paid-In Capital(Or Share Stock) |
2,390,812,402.00 |
| Capital Surplus |
167,140,205.43 |
| Surplus Reserve |
522,452,279.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,156,000,687.92 |
| Minority Stockholder's Interest |
761,910,026.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,281,749,399.59 |
| Owner's Equity（Stockholder's Equity） |
9,043,659,426.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
23,034,814,893.14 |
